Why MACI involves two procedures before recovery even begins

Before the rehabilitation clock even starts, MACI already asks something of you: two separate operations, not one. The first is a short arthroscopic procedure to harvest a small sample of your own cartilage cells — chondrocytes — from an undamaged area of the knee. Those cells are then sent to a laboratory, where they are cultured and seeded onto a collagen membrane over several weeks. Only once that graft is ready does the implantation surgery take place.

Active rehabilitation begins after the implantation — the second procedure — and extends for approximately one year from that point. The biopsy and the waiting period in between are a pre-requisite, not part of the rehab timeline itself, but they add meaningfully to the overall time commitment.

Patients should plan for two separate surgical episodes before physiotherapy-led recovery begins in earnest. This two-stage structure is a genuine practical consideration; some newer single-stage scaffolded techniques are designed to remove that interval entirely, though they remain less established in the evidence base. Understanding this sequencing from the outset helps set realistic expectations for the months ahead.

The first nine weeks — weight-bearing and early mobility milestones

Where a lesion sits in the knee makes a meaningful difference to how quickly loading can begin. For tibiofemoral (TF) lesions — those on the weight-bearing surfaces of the femoral condyle or tibial plateau — the Delphi consensus of US orthopaedic surgeons, which achieved greater than 75% agreement across all four rehabilitation domains, places full weight-bearing at 7–9 weeks after implantation. Patellofemoral (PF) lesions follow a different logic: immediate weight-bearing with bracing is considered appropriate from the outset, though the precise protocol depends on any concomitant procedures performed at the same time.

Range of motion progresses in parallel. The same consensus guidelines set 90° of knee flexion as an early clinical target, typically achievable by week 4, with full ROM expected by weeks 7–9 in tibiofemoral cases. These are shared benchmarks among specialists rather than rigid rules; individual progress will vary with lesion size, surgical approach, and patient factors.

One practical reassurance for patients concerned about prolonged immobilisation: a prospective randomised controlled trial comparing 6-week with 8-week return to full weight-bearing found no significant difference in KOOS scores at 1, 2, 5, or 10 or more years of follow-up. The 6-week group reported better KOOS Quality of Life scores at the 1-year mark, and MRI graft appearance was superior at final follow-up — supporting the growing clinical consensus that earlier, progressive loading is safe rather than risky.

This shift toward accelerated rehabilitation is reflected more broadly in the current literature. Tools such as blood flow restriction (BFR) training allow physiotherapists to build muscle strength with lower mechanical loads during the early protected phase — a practical option in the weeks before full weight-bearing is permitted, rather than a replacement for the staged progression itself.

Three to six months — monitoring the graft as it settles

Three months after implantation, many patients find themselves in an uncomfortable middle ground: the initial post-surgical soreness has eased, the crutches are gone, yet the knee still does not feel entirely their own. Part of what is happening during this period is visible on MRI — and understanding it makes the monitoring schedule feel less arbitrary.

The bone directly beneath a MACI graft commonly shows a swelling-like signal on imaging in the early months, a finding clinicians describe as a subchondral bone marrow oedema-like lesion, or BMEL. This is a normal part of the healing response, not a sign of failure. Research tracking 18 patients after MACI found an average BMEL volume of approximately 4.9 cm³ at three months; by two years, that volume had roughly halved to around 2.0 cm³ as the subchondral bone settled. These figures are a guide rather than a guarantee — the cohort is small — but they give a useful sense of the direction of travel.

What makes the six-month review clinically meaningful rather than simply administrative is that elevated BMEL volume at that point independently predicted lower Lysholm and MOCART 2.0 scores at two years. In other words, how well the bone beneath the graft is calming down at six months carries information about how the overall repair is progressing. MRI remains the primary tool for assessing both graft fill and subchondral response at this stage, and a result that shows persistent high BMEL volume may prompt closer follow-up or modified loading guidance rather than simple reassurance.

Six months to one year — returning to work, daily life, and sport

The question patients most often raise after the early post-operative phase is straightforward: when can life feel normal again? The honest answer, confirmed by the Delphi consensus of US orthopaedic surgeons, is that return to work, daily activities, and sport each depend on lesion location, lesion size, and individual patient factors — no single agreed week number applies across the board.

In practice, sedentary and desk-based roles become achievable earlier than physically demanding or manual jobs, typically in the weeks after full weight-bearing is established, once pain is controlled and the knee tolerates sustained sitting and walking. Those in manual trades, or on their feet for long periods, routinely require several additional months before the joint is ready for occupational demand.

Return to impact and pivoting sport sits furthest along the timeline. Rather than a specific date, clinicians use objective functional criteria — notably limb symmetry indices for knee extensor strength. In the accelerated weight-bearing RCT, peak extensor torque symmetry reached approximately 100% bilaterally at ten or more years of follow-up, illustrating the level of functional parity a successful graft can ultimately support. Nine to twelve months is a range commonly cited in clinical practice for returning to cutting and contact sport, though some patients reach the required benchmarks earlier and others later; strength testing and sport-specific movement assessment provide clearer readiness signals than the calendar alone.

Blood flow restriction training continues to earn its place across this phase. Applying controlled cuff pressure allows meaningful strength gains at lower mechanical loads than conventional resistance work demands — helping to reverse muscular atrophy during a period when the joint is not yet ready for high-load exercise.

What shapes your personal recovery curve

Several variables sit behind any recovery estimate, and a specialist assessment weighs them together rather than applying one schedule to every patient.

• Lesion size. MACI addresses defects broadly in the 2–10 cm² range. Larger defects within that band involve more tissue to consolidate, which may mean a longer period before the graft is fully integrated and loading is progressed.
• Lesion location. As established by the Delphi consensus, tibiofemoral and patellofemoral lesions follow different early protocols — differing in how soon full weight-bearing begins and how load is reintroduced. Location continues to shape the rehabilitation plan well beyond the first nine weeks.
• Age, BMI, and baseline fitness. These three factors collectively influence how quickly muscle strength returns, how the subchondral bone responds, and how the body tolerates progressive loading. No single modifier dominates; surgeons weigh them together.
• Concomitant osteotomy. For patients with a meaningful alignment problem alongside a cartilage defect, an osteotomy to correct load distribution may be performed at the same time as MACI. This is a planned, deliberate decision — not a complication — but it adds a separate healing dimension that extends the overall rehabilitation timeline.
• Prior marrow-stimulation procedures. Previous microfracture can alter the subchondral bone plate in ways that may affect graft integration. This is one reason a thorough surgical history forms part of every pre-operative assessment.

None of these factors is a reason for anxiety — they are precisely what a pre-operative consultation is designed to map, so that the rehabilitation plan is realistic and matched to the individual from the outset.

Long-term outcomes — what the evidence says at 10 years and beyond

Ten to seventeen years of follow-up data now exist for MACI, and the headline finding is genuinely encouraging. A 2024 systematic review covering 168 patients (mean age 37 years, 188 defects) reported significant and durable improvements in patient-reported outcomes across that timeframe, with satisfactory defect fill confirmed on MRI in the majority of cases.

The failure rates place this in useful context. All-cause reoperation stood at approximately 9% across the study period; conversion to total knee arthroplasty occurred in around 7.4% of patients at 10–17 years. For a procedure targeting younger, active individuals who might otherwise face early joint replacement, those figures support the core logic of cartilage preservation: buying meaningful, functional time — and, in many cases, avoiding replacement altogether.

The evidence has limits worth naming plainly. This is level-4 data — prospective cohort and case series rather than large randomised controlled trials at decade-long follow-up. That does not invalidate the findings, but it does mean individual outcomes vary considerably, and a careful pre-operative assessment of lesion size, location, and patient-specific factors remains essential before drawing conclusions about any particular case. The durability seen in published series reflects patients who completed structured rehabilitation; the two are not separable.

For patients at the point of making this decision, a specialist assessment at the London Cartilage Clinic — where lesion characteristics, surgical history, and rehabilitation feasibility can be evaluated together — can be arranged via londoncartilage.com.

1. [1] Consensus on Rehabilitation Guidelines among Orthopedic Surgeons in the United States following Use of Third-Generation Articular Cartilage Repair (MACI) for Treatment of Knee Cartilage Lesions. (2020). https://doi.org/10.1177/1947603520968876 https://doi.org/10.1177/1947603520968876
2. [2] Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee. (2024). https://doi.org/10.1177/03635465231205309 https://doi.org/10.1177/03635465231205309
3. [3] The Predictive Value of Early Postoperative MRI-Based Bone Marrow Parameters for Mid-Term Outcome after MACI with Autologous Bone Grafting at the Knee. (2022). https://doi.org/10.1177/19476035221093061 https://doi.org/10.1177/19476035221093061
4. [4] A Randomized Controlled Trial Evaluating an Accelerated Weight-Bearing Rehabilitation Pathway after MACI for Symptomatic Knee Cartilage Defects. (2024). https://doi.org/10.31189/2165-7629-13-s2.316 https://doi.org/10.31189/2165-7629-13-s2.316
5. [5] The Evolution of Rehabilitation and Return to Sport Following Cartilage Surgery. (2023). https://doi.org/10.26603/001c.77508 https://doi.org/10.26603/001c.77508
6. [6] Arthroscopic Matrix-Associated Autologous Chondrocyte Implantation for Focal Tibial Defects. (2025). https://doi.org/10.1016/j.eats.2025.103545 https://doi.org/10.1016/j.eats.2025.103545
7. [7] Accelerated Rehabilitation Following Open and Arthroscopic Matrix-Induced Autologous Chondrocyte Implantation (MACI). (2012).